Skip to content
Menu

Alphabet Inc. GOOG

Full chart Compare
Set alert

Price alert · GOOG

All alert types
264.00 USD -7.02 (-2.59%)

Regular-session close

268.50 +4.50 +1.70%

After hours · Nov 20, 7:59 PM ET

262.28 Day range 280.52
264.00 52-week range 399.04
YTD
-15.87%
1 year
-8.96%

Discussion (1203)

StockMaster GOOG 1 month ago #71

$GOOG...WHAT a ridiculous, completely overblown hysteria... I’ve rarely seen such a foolish sell-off. This is no longer Wall Street; it’s a circus and a casino. We’re seeing fantastic earnings—and not just from Big Tech; analyst targets for the hyperscalers are 30–50% higher. And yet, look at how Wall Street is reacting—all because of the geopolitical situation. Many thanks to the worst president in U.S. history.

Tim F GOOG 1 month ago #72

BOB JOE has got some serious but hurt. It’s paying me when this b!tch drops. You need to read the room. The trade has been over and has been advertised since August. Remember the rule, don’t allow your emotions to control you trades.

StockMaster GOOG 1 month ago #75

$GOOG...18–20% below the 52-week high... with a forward P/E of 21... what a load of manipulative bullshit.

StockMaster GOOG 1 month ago #76

$GOOG...GOOGLE’s YouTube will benefit significantly from the weakness in Netflix’s subscriber numbers.Added to this is the power of the cloud, the search engine, and the steadily growing number of Waymo vehicles.

StockMaster GOOG 1 month ago #77

$GOOG...WHO is selling at this level??Ridiculous&irrational..undervalued and forward P/E 21...stupid market

StockMaster GOOG 1 month ago #78

$GOOG...SORRY, but who is actually selling at this level? Even though I’ve been making my living on Wall Street for 26 years, I just don’t get this nonsense—why are hyperscalers like Google and NVIDIA being manipulated to this extent? Based on their earnings, valuations, and analyst recommendations, both should be trading 20% ​​higher.

Zeev Bovan GOOG 1 month ago #79

Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Protara Therapeutics
October 15, 2026 08:00 ET

$TARA

Sign in to join the discussion